as Altace (Sonfi) and Ramipril (Pharmascience). Ramipril is marketed in India under the brand names Cardace, Zigpril, Ramistar, Odipril and Zorem . Ramipril is marketed in Myanmar under brand name Endpril . Research The Heart Outcomes and Prevention Evaluation trial seemed to show ramipril possessed cardioprotective qualities which extended beyond its qualities as an antihypertensive. However, the trial and the interpretation of its results have been criticised. The Acute Infarction Ramipril Efficacy (AIRE) trial showed a 27% reduction in mortality for patients receiving ramipril for chronic heart failure following a myocardial infarction. Ramipril was found to have similar results as telmisartan, an angiotensin II receptor blocker. References External links ACE inhibitors Carboxamides Carboxylic acids Enantiopure drugs Ethyl esters Prodrugs Sanofi Pfizer brands AstraZeneca brands Wikipedia medicine articles ready to translate